MARGUERITE VITULSKI: Open Payments
NPI 1285805655 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$242 in 11 payments from 8 companies in 2025. Trend: 2023 $28 · 2024 $413 · 2025 $242
Food & beverage: $242
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Daiichi Sankyo Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Janssen Biotech, Inc. | 1 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| UCB, Inc. | 1 | $14 |
Products named: ENTYVIO, INJECTAFER, NUCALA, TREMFYA, ONPATTRO, SKYRIZI, Cimzia.
Industry payments across IL — which companies pay providers there.
